Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in Relapsed/Refractory SCLC
NCT00984542Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in small cell lung cancer (SCLC), sponsored by Vanderbilt-Ingram Cancer Center. Started Sep 2009; status: completed.
02
Drugs
bendamustine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00984542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984542.